Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys


These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Friday, 29 May, as follows:

Autodesk Inc. (NASDAQ:ADSK) was reiterated as Buy and its price target was raised to 230 from 195 at Canaccord Genuity. KeyBanc Capital Markets reiterated its Overweight rating and raised its price target to 223 from 210.

EverQuote Inc. (NASDAQ:EVER): this stock has some really big growth and margins that are headed in the right direction. Shares most recently closed at 52.30, with a consensus price target of 47.83.

IGM Biosciences Inc. (NASDAQ:IGMS) was started as Buy with a 86 price target at SunTrust Robinson Humphrey, which noted that the company is on the way to new therapeutic antibodies.

Karuna Therapeutics Inc. (NASDAQ:KRTX) was started with a Buy rating and a $140 price target (versus an $87.97 close) at H.C. Wainwright.

Leggett & Platt Inc. (NYSE:LEG) was reiterated as Strong Buy and its target was raised to 38 from 33 at Raymond James.

Have a healthy weekend, Keep the Faith!

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge. Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he it the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.